Waddell & Reed Financial’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$28.9M Buy
848,293
+33,882
+4% +$1.29M 0.06% 318
2020
Q4
$27.1M Buy
814,411
+41,322
+5% +$1.51M 0.06% 328
2020
Q3
$24.8M Buy
773,089
+546,040
+240% +$15.7M 0.06% 317
2020
Q2
$6.25M Buy
+227,049
New +$5.38M 0.02% 410

Other funds holding INSM

Waddell & Reed Financial's INSM Position: Q1 2021 in Review

Waddell & Reed Financial increased its Insmed (INSM) stake by 4.2% in Q1 2021, buying an estimated $1.29M and bringing the position to 848,293 shares worth $28.9M. The position accounts for 0.06% of the portfolio, ranked #318.

Waddell & Reed Financial first reported a position in INSM in Q2 2020 and has held it in 4 quarters since. 199 funds tracked by Wall St. Rank hold INSM as of Q1 2021.

  • Waddell & Reed Financial held 848,293 shares of Insmed worth $28.9M as of Q1 2021.
  • Waddell & Reed Financial bought 33,882 Insmed shares in Q1 2021, an estimated $1.29M.
  • Insmed made up 0.06% of Waddell & Reed Financial's portfolio in Q1 2021, its #318 holding.
  • Waddell & Reed Financial first reported a position in Insmed in Q2 2020 and has held it in 4 quarters since.
  • 199 funds tracked by Wall St. Rank held Insmed as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.